Nuveen Asset Management, LLC Day One Biopharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 163,698 shares of DAWN stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,698
Previous 190,906
14.25%
Holding current value
$2.09 Million
Previous $2.63 Million
13.31%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
84.2MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$101 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$82.1 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$75.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$62.2 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$57.9 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $938M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...